Table I.
Demographic, clinical and genetic data of patients with DVT.
| Characteristic | Patient data |
|---|---|
| Sex | |
| Male/Female | 20/7 |
| Mean age, years | 42 (range, 24-70) |
| Site of thrombosis | |
| Lower extremity | 25 |
| Upper extremity | 1 |
| Pulmonary embolism | 1 |
| Oral anticoagulant use | |
| Warfarin | 24 |
| Rivaroxaban | 3 |
| Frequency of Kelch-like ECH-associated protein 1 mutations | 24 (88%) |
| Frequency of nuclear factor erythroid-2-like 2 mutations | 14 (52%) |
| Frequency of FV G/A | 7 (26%) |
| Frequency of FV A/A | 6 (22%) |
| Frequency of PT G/A | 4 (15%) |
| Frequency of PT A/A | 0 |
| Hypertension | 6 (22%) |
| White blood cells, x109/l | 8.22 (5.80-14.40) |
| Red blood cells, x109/l | 5.22 (4.15-6.98) |
| Partial thromboplastin time | 40.27±9.05 |
| Thromboplastin time | 22.66±6.66 |
| International normalized ratio | 1.98±0.57 |
| Hemoglobin, g/dl | 15.01±1.58 |
| Hematocrit, % | 44.68 ±4.52 |
| Mean corpuscular volume, fl | 86.38±8.51 |
| Mean corpuscular hemoglobin, pg | 29.05±3.26 |
| Platelet count, x109/l | 239.8 (139.0-355.0) |
| Red blood cell distribution width, % | 13.86±1.11 |
| Procalcitonin, % | 0.22±0.06 |
| Platelet distribution width, % | 16.01±0.43 |
| Mean platelet volume, fl | 9.11±1.15 |
FV, factor V; PT, prothrombin.